Please use this identifier to cite or link to this item:
|Title:||Maximizing patient recruitment and retention in a secondary stroke prevention clinical trial: lessons learned from the STAND FIRM study.|
|Other Authors:||Thayabaranathan, T.|
Srikanth, V. K.
Evans, R. G.
Phan, T. G.
Bladin, C. F.
Nelson, M. R.
Thrift, A. G.
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Trials, Randomized Clinical
Clinical Trials, Randomized
Department of Medicine, Epworth Healthcare, Australia.
|Citation:||J Stroke Cerebrovasc Dis. 2016 Mar 18. pii: S1052-3057(16)00106-3|
|Abstract:||BACKGROUND: Recruitment and retention of patients in a clinical trial is important for generalizability and robustness of findings. We aimed to investigate features of a study design that were associated with recruitment and retention in a Phase II and Phase III trial of a secondary prevention program for stroke. METHODS: Following informed consent in hospital, Phase II participants were randomized to intervention or usual care. Baseline clinical assessments were conducted at home approximately 3 months after discharge. In Phase III study, informed consent was obtained at home. We compared the characteristics of participants recruited and retained to 12 months for both phases. Interviews with study nurses were undertaken in order to ascertain their opinions of features of study design. Triangulation was used to identify the features of study design that nurses thought had improved recruitment and retention. RESULTS: All 24 eligible participants were recruited to the Phase II pilot study (100% recruitment), with 67% retention at 12 months. In Phase III study, 570 participants were recruited, and 93% of these participants had reached their 12-month assessment (n = 532) and were still participating. Consistent with the greater patient retention in Phase III study, nurses reported that patients' willingness to participate was greater when consent was obtained at home. CONCLUSION: Following a change in the consent process from hospital to home, more participants continued participation to 12 months. Pilot studies can provide important data to improve study design and better understand potential barriers to recruitment and retention.|
|Journal Title:||Journal of Stroke and Cerebrovascular Diseases|
|Affiliated Organisations:||Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.|
Department of Physiology, Monash University, Melbourne, Victoria, Australia.
Stroke Division, Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia.
Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia.
Menzies Research Institute Tasmania, Hobart, Tasmania, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Neurosciences, Box Hill Hospital, Monash University, Box Hill, Victoria, Australia.
Department of Medicine, Box Hill Hospital, Monash University, Box Hill, Victoria, Australia.
School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
Department of Neurology, The Alfred Hospital, Prahran, Victoria, Australia.
|Type of Clinical Study or Trial:||Feasibility Study|
|Appears in Collections:||Neurosciences|
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.